Back to Search Start Over

High-throughput screening paradigms in ecotoxicity testing: Emerging prospects and ongoing challenges.

Authors :
Wlodkowic D
Jansen M
Source :
Chemosphere [Chemosphere] 2022 Nov; Vol. 307 (Pt 2), pp. 135929. Date of Electronic Publication: 2022 Aug 06.
Publication Year :
2022

Abstract

The rapidly increasing number of new production chemicals coupled with stringent implementation of global chemical management programs necessities a paradigm shift towards boarder uses of low-cost and high-throughput ecotoxicity testing strategies as well as deeper understanding of cellular and sub-cellular mechanisms of ecotoxicity that can be used in effective risk assessment. The latter will require automated acquisition of biological data, new capabilities for big data analysis as well as computational simulations capable of translating new data into in vivo relevance. However, very few efforts have been so far devoted into the development of automated bioanalytical systems in ecotoxicology. This is in stark contrast to standardized and high-throughput chemical screening and prioritization routines found in modern drug discovery pipelines. As a result, the high-throughput and high-content data acquisition in ecotoxicology is still in its infancy with limited examples focused on cell-free and cell-based assays. In this work we outline recent developments and emerging prospects of high-throughput bioanalytical approaches in ecotoxicology that reach beyond in vitro biotests. We discuss future importance of automated quantitative data acquisition for cell-free, cell-based as well as developments in phytotoxicity and in vivo biotests utilizing small aquatic model organisms. We also discuss recent innovations such as organs-on-a-chip technologies and existing challenges for emerging high-throughput ecotoxicity testing strategies. Lastly, we provide seminal examples of the small number of successful high-throughput implementations that have been employed in prioritization of chemicals and accelerated environmental risk assessment.<br />Competing Interests: Declaration of competing interest Marcus Jansen is a Chief Scientist - Biology at the LemnaTec GmbH. No funding or other financial support was received for this work.<br /> (Copyright © 2022 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1879-1298
Volume :
307
Issue :
Pt 2
Database :
MEDLINE
Journal :
Chemosphere
Publication Type :
Academic Journal
Accession number :
35944679
Full Text :
https://doi.org/10.1016/j.chemosphere.2022.135929